Archives for October 31, 2005

← 2005

BioGaia 'is approaching profitability'

By  Jess Halliday

Swedish probiotic biotech company BioGaia is making headway in its short-term mission to attain profitability, reporting a 39 percent increase in sales to SEK 16.4 million for 3Q 2005.

SierraSil study suggests osteoarthritis relief

By  Staff Reporter

A combination of natural minerals from the Sierra Mountains shows promise in reducing the pain of arthritis, according to a study published in the Journal of Inflammation.

Jury still out on probiotics for IBS

By  Staff Reporter

The role of probiotics in alleviating the symptoms of irritable bowel syndrome (IBS) came under the spotlight at the annual meeting of the American College of Gastroenterology this weekend. The conclusion of two review studies presented was that...

Enzyme giant Novozymes reports solid growth

By  Anthony Fletcher

Continual productivity improvements are behind Novozymes' solid performance since it was floated on the stock market in 2000, according to CEO Steen Riisgaard.

Advitech aims for psoriasis deal by year-end

By  Staff Reporter

Advitech is embroiled in discussions with potential partners to bring its XP-828L product to market, targeting sufferers of mild to moderate psoriasis and other inflammatory diseases.